From this analysis, percent variability (%) in CD8 counts between step sections from colonic adenocarcinoma (0.2%), medullary breast carcinoma (0.1%) and ductal adenocarcinoma (0.1%) blocks were minor. This evidence concerns the gene CD8A and medullary breast carcinoma.